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Abstract
RIG-I-like receptors (RLRs: RIG-I, MDA5 and LGP2) play a major role in the innate immune response against viral infections
and detect patterns on viral RNA molecules that are typically absent from host RNA. Upon RNA binding, RLRs trigger a
complex downstream signaling cascade resulting in the expression of type I interferons and proinflammatory cytokines. In
the past decade extensive efforts were made to elucidate the nature of putative RLR ligands. In vitro and transfection studies
identified 59-triphosphate containing blunt-ended double-strand RNAs as potent RIG-I inducers and these findings were
confirmed by next-generation sequencing of RIG-I associated RNAs from virus-infected cells. The nature of RNA ligands of
MDA5 is less clear. Several studies suggest that double-stranded RNAs are the preferred agonists for the protein. However,
the exact nature of physiological MDA5 ligands from virus-infected cells needs to be elucidated. In this work, we combine a
crosslinking technique with next-generation sequencing in order to shed light on MDA5-associated RNAs from human cells
infected with measles virus. Our findings suggest that RIG-I and MDA5 associate with AU-rich RNA species originating from
the mRNA of the measles virus L gene. Corresponding sequences are poorer activators of ATP-hydrolysis by MDA5 in vitro,
suggesting that they result in more stable MDA5 filaments. These data provide a possible model of how AU-rich sequences
could activate type I interferon signaling.
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Introduction
The retinoic acid inducible gene I (RIG-I)-like receptor (RLR)
proteins are key players in innate immunity and act by recognizing
viral RNA (vRNA) in the cytosol. The RLR family consists of
the members retinoic acid inducible gene I (RIG-I), melanoma
differentiation associated protein 5 (MDA5), and laboratory of
genetics and physiology 2 (LGP2) [1–3]. In vitro studies have shown
that RIG-I and MDA5 recognize the majority of viruses in a
complementary manner. While many negative-strand RNA
viruses like rabies and influenza viruses are predominantly sensed
by RIG-I, picornaviruses are predominantly recognized by
MDA5. The observed preferences are, however, unlikely to be
exclusive and the exact role of LGP2 still needs to be investigated
[4–9]. In case of MDA5, a minor contribution to recognition of
measles, rabies, vesicular stomatitis and Sendai virus has been
reported [10–13].
The RLR proteins belong to the DExD/H-box ATPases
sharing a central ATP-dependent helicase domain and a C-
terminal regulatory domain (RD) that is responsible for initial
RNA binding. In addition, RIG-I and MDA5 possess N-terminal
tandem caspase activation and recruitment domains (CARDs) that
are responsible for downstream signaling transduction [2,14,15].
Several crystal structures of RIG-I have shown that, in the absence
of virus, the protein exists in an auto-inhibited state where the RD
domain folds back to the CARDs, thereby shielding them from the
cytosol. Upon viral infection and initial vRNA binding, the protein
undergoes large conformational changes leading to the interaction
with the mitochondrial associated signaling protein (MAVS) [16–
19]. This leads to the activation of a downstream signaling cascade
and finally to the induction of type I interferon (IFN) expression
and the establishment of an anti-viral state. Although the exact
nature of RLR ligands is not yet fully understood, several studies
report that RIG-I preferentially binds to relatively short (between
25 to 1000–2000 bp) 59-triphosphate double-stranded RNAs
(59-triphosphate dsRNA) like those of Sendai virus (SeV) defective
interfering (DI) particles [20–23]. In contrast, MDA5 seems to
have a preference for long (more than 1000–2000 bp) dsRNA
stretches [24,25]. Upon binding to dsRNA, MDA5 is thought to
cooperatively form polar helical filaments leading to association
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with MAVS and activation of the downstream signaling cascade
[26–28].
Viruses have developed numerous strategies to evade the
immune system. For instance, viruses of the paramyxovirus family
(e.g. measles, parainfluenza, Sendai and Nipah viruses) encode
V inhibitor proteins that specifically bind to MDA5 and LGP2,
but not always to RIG-I [29–31]. By determining the structure
of MDA5 in complex with parainfluenza virus V-protein, we
previously showed that the viral protein unfolds the ATPase
domain of MDA5. This leads to the disruption of the MDA5
ATP-hydrolysis site and prevents RNA bound MDA5 filament
formation [32].
One of the remaining key questions in this field is how RLR
proteins are able to distinguish between self and non-self RNA in
the cytosol. Recently, several studies showed that 59-triphosphate
RNA is not the only RNA ligand for RIG-I. Specific poly U/C-
rich regions within certain viral genomes seem to contribute to
efficient recognition by the protein [33,34]. In case of MDA5, it is
not known which features of vRNA are required in order to induce
an immune response. Expression of subgenomic and subgenic
RNA from parainfluenza virus 5 (PIV5) indicated that MDA5
recognizes a specific region within the L mRNA [35]. For
picornaviruses, it is speculated that MDA5 binds to long dsRNA
that represents replicative intermediates composed of the positive
genome and the negative antigenome [36]. These studies were,
however, based on in vitro transfection experiments and it has so far
not been possible to isolate a natural RNA ligand for MDA5
directly from virus-infected cells.
In this study we combined different methods, including RNA-
protein crosslinking and deep sequencing, to investigate in vivo
RNA ligands for RLR proteins from virus-infected cells. Based on
the crosslinking we were able to co-purify immunostimulatory
RNA in a RIG-I and MDA5 dependent manner from measles
virus (MeV)-infected cells. Deep sequencing and bioinformatics
analysis revealed that RIG-I and MDA5 bind RNA of positive
polarity originating from the L gene of the MeV genome. In
addition, RIG-I binds to the 59 ends of genomic and antigenomic
RNAs, which probably represent 59-triphosphate RNA, and are
therefore not recognized by MDA5. Furthermore, we showed that
RIG-I, but not MDA5, binds RNA of negative polarity, indicating
that MDA5 does not efficiently recognize the MeV genome. Based
on bioinformatics analysis, we observed a correlation between
MDA5-enriched RNA sequences and the AU content and this was
confirmed by in vitro transcription assays. In summary, we report
the isolation of MDA5-associated RNA from virus-infected cells
and the discovery of in vivo occurring activating viral RNA ligands
for MDA5.
Results
4-thiouridine treatment and 365 nm UV light exposure
lead to improved RLR-associated RNA recovery from
virus-infected cells
Several in vitro studies showed that MDA5 preferably recognizes
long dsRNA stretches [24,25]. However, it is still unclear if the
protein has a preference for specific RNA sequences. The main
reason for this may lie in the weak interaction between the protein
and its ligand resulting in very poor RNA levels that co-purify
from MDA5 immunoprecipitates. In order to address this
problem, we established an RNA-protein crosslinking approach
adapted from the PAR-CLIP (Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation) methodology
[37]. With this approach, we intended to improve RNA recovery
from RLR immunoprecipitates in the context of a viral infection.
For validation of the method, we compared the crosslinking
approach with a conventional pull-down technique previously
used for the identification of SeV DI particles as potent RIG-I
inducers [20]. We infected A549 human lung carcinoma cells with
SeV at a high multiplicity of infection (MOI) in the presence of 4-
thiouridine (4SU) and allowed infection to occur over 24 h. A part
of the cells was then exposed to 365 nm UV light and endogenous
RIG-I was immunopurified (Figure 1a). The recovered RNA was
isolated and subjected to quantitative PCR (qPCR) analysis and
immunoactivity experiments. The data indicate that treatment
of cells with 4SU and exposure to 365 nm UV light lead to a
reduction of immunostimulatory activity of RIG-I-associated
RNA to 50% (Figure 1b). However, the results of qPCR analysis
showed that the crosslinking approach yields a quantitatively
improved RNA recovery, with an increase of 50% in SeV DI
particles in comparison to the non-crosslinking approach
(Figure 1c and d). Furthermore, we confirmed that treatment
of cells with the photoreactive nucleoside does not affect cell
viability or virus replication (data not shown). Taken together, our
data indicate that the crosslinking technique is a promising tool to
study in vivo occurring RNA ligands for RLR proteins.
Next, we validated the crosslinking approach on cells that were
infected with a variety of viruses, including negative-stranded (2)
RNA viruses (MeV [38] and rabies [39]) and positive-stranded (+)
RNA viruses (Encephalomyocarditis virus (EMCV [40]) and
Mengo virus [41]). In all cases, we infected A549 cells at an
MOI of 1.0 in the presence of 4SU. Cells were crosslinked 24 h
post infection (hpi) and RIG-I and MDA5 were immunopurified.
The recovered RNA was subjected to immunoactivity experi-
ments. Based on the data, we concluded that immunoactive RNA
was co-purified in a RIG-I- and MDA5-dependent manner from
MeV-infected cells. This induction was significant in comparison
to the negative control (Figure 2). In the case of RIG-I-associated
RNA, we obtained an immunostimulatory effect that was 2600-
fold higher in comparison to the control. For MDA5, we observed
an 800-fold induction. The data show that the approach yields
RIG-I- and MDA5-specific immunoactive RNA from MeV-
infected cells in a RIG-I- and MDA5-dependent manner.
Author Summary
RIG-I-like receptors (RLRs) are helicase-like molecules that
detect cytosolic RNAs that are absent in the non-infected
host. Upon binding to specific RNA patterns, RLRs elicit a
signaling cascade that leads to host defense via the
production of antiviral molecules. To understand how RLRs
sense RNA, it is important to characterize the nature and
origin of RLR-associated RNA from virus-infected cells.
While it is well established that RIG-I binds 59-triphosphate
containing double-stranded RNA, the in vivo occurring
ligand for MDA5 is poorly characterized. A major challenge
in examining MDA5 agonists is the apparently transient
interaction between the protein and its ligand. To improve
the stability of interaction, we have used an approach to
crosslink MDA5 to RNA in measles virus-infected cells. The
virus-infected cells were treated with the photoactivatable
nucleoside analog 4-thiouridine, which is incorporated in
newly synthesized RNA. Upon 365 nm UV light exposure
of living cells, a covalent linkage between the labeled RNA
and the receptor protein is induced, resulting in a higher
RNA recovery from RLR immunoprecipitates. Based on
next generation sequencing, bioinformatics and in vitro
approaches, we observed a correlation between the AU-
composition of viral RNA and its ability to induce an
MDA5-dependent immune response.
In Vivo Ligands of MDA5 and RIG-I
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Although we detected significant immunostimulatory activity for
RLR-associated RNAs from MeV-infected cells, the experimental
set up is currently unsuitable for the isolation of RLR RNA ligands
from the other viruses (Figure S1). The reason for this may lie
in the heterogeneity and the need for precise timing of viral
replication cycles or in the efficiency of 4SU incorporation and
crosslinking. Utilization of this technique for other viruses may
require adjustment of parameters, such as the time points of 4SU
addition, crosslinking and harvesting after infection.
Deep sequencing reveals regions within the measles
virus genome recognized by RIG-I and MDA5
Based on the above-mentioned results, we focused our studies
on MeV, which belongs to the order of Paramyxoviridae. MeV has a
single-stranded RNA genome of negative polarity consisting of
15,894 nucleotides. It comprises six non-overlapping genes,
which are flanked by small terminal non-coding regions known
as leader (le) and trailer (tr) sequences. These sequences serve as
promoter regions during viral replication and transcription
[42,43]. While the replication of the genome and antigenome is
performed in a continuous process, viral transcription is carried
out in a sequential manner, giving rise to an mRNA gradient
declining in the 39 to 59 direction (Figure S2), as previously
published [44]. Since (2) RNA virus polymerases eventually fail in
transcription termination, they generate, in addition to mono-
cistronic mRNAs, numerous alternative RNA species including
read-through transcripts, such as leader-N, bi- or tricistronic
mRNAs [45]. Furthermore, replication can give rise to abortive
replication products and DI RNA with large internal deletions or
copy-back genomes [46]. Due to the complex RNA composition of
Figure 1. Validation of crosslinking and immunoprecipitation of RLR/RNA complexes from 24 h virus-infected cells. A: Schematic
representation of the experimental procedure for characterization of RLR-associated RNA molecules. B: Immunostimulatory activity of RNA from RIG-I
and control (GFP) crosslinking samples in comparison to non-crosslinking immunoprecipitates. C: Western blot analysis of crosslinked and non-
crosslinked RIG-I and control (GFP) pull-down experiments. D: Comparison of RNA recovery levels by quantitative PCR analysis of RIG-I-associated
RNA from SeV-infected cells (n = 3). n.d. = not detectable.
doi:10.1371/journal.ppat.1004081.g001
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a virus-infected cell, the analysis of specific RNA ligands for RLR
proteins is challenging.
In order to shed light on the exact nature of RIG-I and MDA5-
associated RNAs derived from MeV-infected cells, we performed
a deep sequencing analysis on isolated RNA species from co-
immunopurifications with antibodies against endogenous RIG-I
and MDA5. As a control, we used an antibody against GFP (GFP
protein was not present). The MeV strain used for the studies
presented here was a recombinant measles virus rescued from
cDNA with the exact sequence of the Schwarz vaccine strain
(Genbank AF266291.1) [38].
Obtained sequences were mapped to the MeV antigenome and
the relative abundances of these sequences between RIG-I pull-
down, MDA5 pull-down, and GFP pull-down were compared.
Analysis of the reads showed that RIG-I and MDA5 bind to similar
regions within the L gene-derived RNAs. In addition, RIG-I,
but not MDA5, binds to RNAs derived from the 39 and the 59 ends
of the MeV genome (Figure 3a and b). These regions probably
represent le or trRNA generated in the course of replication or
transcription. Additionally, internal genomic and antigenomic
sequences found in the pull-downs could potentially originate from
MeV DI particles [46–51]. To address this question, we performed
a PCR analysis of RLR libraries in which we specifically amplified
copyback DI RNA of MeV [47–49]. Indeed, we detected copyback
DI particles not only in the RIG-I pull-down but also within RNA
recovered from MDA5 immunoprecipitates (Figure S3). We did
not find DIs in the GFP control pull-downs.
Consistent with previous work, the higher copy numbers of
reads indicate that RIG-I binds MeV RNA with higher affinity
than MDA5 [11]. This observation is in good agreement with
the increased immunostimulatory activity of isolated RNA from
RIG-I pull-down samples in comparison to MDA5. Regarding
the immunostimulatory activity, RIG-I-associated RNA gives a
4-fold higher induction in comparison to MDA5-associated RNA
(Figure 3d and e).
Analysis of deep sequencing data reveals remarkable
differences in the strand-specificity of RIG-I and MDA5
Based on the protocol used for cDNA library preparation,
sequencing reads could be separated according to their strand
orientation. During cDNA synthesis, adaptors were specifically
ligated to the 39 or 59 ends, thereby keeping the information of
strand specificity during the deep sequencing run. Separation of
sequences revealed remarkable differences between both protein
immunoprecipitations. RIG-I associated RNA sequences of
positive polarity, which represent either antigenomic RNA or
mRNA transcripts, are enriched in regions close to the 59 end of
the viral antigenome (leader) but also in distinct regions within the
L gene. In contrast, sequences of negative polarity, representing
the viral genome, are exclusively enriched in the 59 end of the
genome (trailer region) and in regions of the L gene (Figure 4a).
Analysis of MDA5-associated RNA revealed that sequences of
positive polarity were enriched within the L gene originating from
similar regions as (+) RNA from the RIG-I library (Figure 4b).
In contrast to RIG-I, however, MDA5 did not bind to RNA
sequences comprising the 59 end of the antigenome or leader
RNA. Comparison of (2) RNA from RIG-I and MDA5 libraries
further revealed that, in contrast to RIG-I, MDA5 did not enrich
sequences of negative polarity, including trailer sequences.
According to the analysis of strand specific enrichment, it
appears that MDA5 does not bind vRNA of negative polarity that
represents the MeV genome. Furthermore, the data evidently rule
out the possibility that MDA5 recognizes RNA duplexes of (+)
and (2) RNA that might represent replication intermediates, as
previously suggested for a positive-strand RNA virus [36]. In fact,
the result suggests that MDA5 binds (+) RNA that could either
represent mRNA or the MeV antigenome.
To further validate the specificity of the accumulation of RIG-I
and MDA5-associated RNA, we calculated specific read enrich-
ments [52] of the RLR libraries compared to the control library
(Figure S4). Enrichment (greater than 26 compared to the
control library) of RIG-I-associated RNA of positive polarity can
be found across the whole genome, whereas only few reads of
negative polarity are enriched within the N and L segment. In
contrast, enriched sequences of MDA5-associated RNA are
exclusively present within the L segment of positive polarity,
whereas no specific enrichment was observed for (2) RNA.
Based on the data, we observed a good correlation between the
deep sequencing analysis and enrichment calculations, indicating
that distinct regions within the MeV genome are indeed
specifically enriched in a RIG-I- and MDA5-dependent manner
in comparison to the control.
Confirmation of deep sequencing data with quantitative
PCR
To independently validate the relative amount of RLR-
associated RNA, qPCR amplification was performed. The
obtained copy read numbers were normalized to the GFP negative
control in order to compare the genomic segments in the RIG-I
and MDA5 samples (Figure 5a). Analysis of relative abundances
confirmed that RIG-I specifically enriches sequences from the
39 and 59 regions of the MeV genome, representing either
antigenome or viral mRNA. Interestingly, the analysis showed
that RIG-I-associated RNA from the genomic 39 end most likely
represents leader read-through transcripts or abortive replication
products and not N mRNA. In MDA5 pull-downs, RNA was
enriched in the case of the L mRNAs and partly in the case of H
mRNAs, while no relevant copy numbers were obtained at other
genomic positions. This is in good agreement with the results of
Figure 2. Immunoprecipitation of RLR-associated RNA from
24 h MeV infections. Validation of immunostimulatory activity of
RNA from RIG-I, MDA5, and GFP immunoprecipitates upon transfection
into 293T ISRE-FF reporter cells (n = 3, ** P,0.01).
doi:10.1371/journal.ppat.1004081.g002
In Vivo Ligands of MDA5 and RIG-I
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Figure 3. Deep sequencing analysis of RLR-associated RNA from MeV-infected cells. A–C: RNA from RIG-I pull-down (red), MDA5 pull-
down (blue), and control (GFP) pull-down (black) from MeV-infected cells were subjected to Illumina deep sequencing analysis. Obtained sequencing
reads are mapped to their position on the viral antigenome. The x-axis corresponds to all possible 15,894 positions in the MeV antigenome and the y-
axis shows the number of reads at the respective position. (A) RIG-I-associated sequences in comparison to the control mapped to the viral
antigenome. (B) MDA5-associated sequences in comparison to the control mapped to the viral antigenome. (C) Overlay of RIG-I associated and
MDA5-associated sequences. D: Western blot analysis of RIG-I and MDA5 immunopurification in comparison to the GFP pull-down. E: Validation of
immunostimulatory activity of RNA from RIG-I, MDA5, and GFP immunoprecipitates upon transfection into 293T ISRE-FF reporter cells.
doi:10.1371/journal.ppat.1004081.g003
In Vivo Ligands of MDA5 and RIG-I
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the deep sequencing analysis, indicating that MDA5 indeed
recognizes RNA originating from the L gene of the MeV genome.
Furthermore, comparison of the relative copy numbers between
RIG-I and MDA5 revealed remarkable differences between both
proteins. The relative abundances in the RIG-I sample were up to
40-fold higher in comparison to MDA5. This observation again
indicates that RIG-I has a higher affinity for MeV RNA sequences
in comparison to MDA5. Our conclusion is further supported by
immunoactivity experiments, where the relative immunostimula-
tory activity of RIG-I-associated RNA was 20-fold higher in
comparison to MDA5 (Figure 5b and c).
Bioinformatics analysis reveals a preferred binding of
RIG-I and MDA5 to RNA species with a higher AU
composition
To elucidate the exact nature of sequences enriched by RIG-I
and MDA5 immunoprecipitations, we conducted a bioinformatics
analysis. For this, the complete genome was divided into fragments
of size 201 nt with a shifting window of 5 nt. Each sequence was
folded in silico (RNAfold [53]) and several RNA primary and
secondary structure features were analyzed. The analyzed para-
meters were set in relation to the mean coverage of sequencing
reads from RIG-I and MDA5 pull-down experiments. Heat scatter
plots indicate that sequences rich in AU correlate with a high
mean coverage of sequencing reads in both the RIG-I (cor =
0.273, cor = 0.334) and MDA5 (cor = 0.358, cor = 0.348) libraries
(Figure 6a and b). These data suggest that RIG-I and MDA5
preferably bind to AU-rich sequences originating from the viral
genome. Although we further analyzed a variety of secondary
structure parameters, including paired nucleotides and bulges, we
did not see any other relevant correlation with the mean coverage
of sequencing reads (Figure S5 and Figure S6).
Confirmation of deep sequencing analysis by
immunoactive experiments on in vitro transcripts
To further confirm the obtained sequencing data, we generated
17 single-stranded, 200 nucleotide long in vitro transcripts (IVTs)
covering different regions of the MeV antigenome (Table S1).
RNAs were double-dephosphorylated in order to ensure that
59-triphosphate groups were removed. For immunoactivity
Figure 4. Strand separation of sequencing libraries into (+) and (2) MeV RNA. RNA deep sequencing libraries were generated based on the
strand-specific mRNA sample preparation protocol from Epicentre. The Epicentre protocol encompasses sequential ligation of 59 and 39 adapters to
RNA molecules, thus preserving strandness information. A: RIG-I-associated sequences in comparison to the control mapped to the viral antigenome.
(+) RNA is shown in red; (2) RNA is shown in magenta; the control library is shown in black and grey. B: MDA5-associated sequences in comparison to
the control mapped to the viral antigenome. (+) RNA is shown in blue, (2) RNA is shown in cyan; the control library is shown in black and grey.
doi:10.1371/journal.ppat.1004081.g004
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Figure 5. Quantitative PCR analysis of RLR-associated RNA from MeV-infected cells. A: Comparison of RNA levels between RIG-I and
MDA5 immunoprecipitates for each genomic segment at 24 hpi. Relative RNA ratios were normalized against the control (GFP) library (mean values, n = 2).
B: Western blot analysis of RLR pull-down experiments in comparison to the GFP pull-down. C: Immunostimulatory activity of RLR-associated RNA at 24 hpi.
doi:10.1371/journal.ppat.1004081.g005
Figure 6. Heatscatter plots of AU content of 201 nucleotide MeV RNA fragments and the fragment’s mean coverage. The linear
correlation is expressed via the Pearson coefficient. Every dot corresponds to one fragment with its respective AU content and mean coverage within
an RLR library. The more yellow the plot, the more data points overlap. A: Correlation between AU composition and coverage of RIG-I-associated RNA
of positive and negative RNA respectively. B: Correlation between AU composition and coverage of MDA5-associated RNA of positive and negative
RNA respectively.
doi:10.1371/journal.ppat.1004081.g006
In Vivo Ligands of MDA5 and RIG-I
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experiments IVTs were transfected into 293T ISRE-FF reporter
cells. The stimulatory effect revealed a correlation of high read
numbers from deep sequencing analysis and high stimulatory
activity of the IVT sequences (Figure 7). According to the
immunostimulatory experiment, we observed increased immunos-
timulatory activities for transcripts 8, 9, and 12 (Figure 7a). These
transcripts correspond to regions at the 59 end of the L gene,
which is also the region with the highest copy numbers of reads
(Figure 3). In general, IVTs representing regions within the L
gene have higher immunostimulatory activity in comparison to
the upstream genomic segments. This is in good agreement to
the deep sequencing analysis. Furthermore, calculated Pearson
correlations showed that the best correlation between maximal
numbers of sequencing reads and the immunostimulatory activity
of RNA transcripts can be found in the MDA5 sequencing data
(cor = 0.526), while RIG-I and GFP samples showed less
correlation (cor = 0.369 and cor = 0.217) (Figure 7b). In order
to find a possible explanation for the different immunostimulatory
potentials of IVTs, several characteristics of the transcripts were
analyzed in silico. The obtained data revealed that the immu-
nostimulatory potential correlates with the AU content of IVTs
(cor = 0.599) (Figure 7d), which is consistent with the results
from the deep sequencing analysis. Visualization of transcripts on
an Agilent bioanalyzer RNA chip indicates that no higher-order
structures due to the sequence composition were formed that
might explain differences in immunostimulatory activity (data not
shown).
In order to get a more general conclusion about the
contribution of the AU content to the immunostimulatory
potential of RNAs, in vitro transcripts from Mengo virus (Table
S3) were tested for their immunostimulatory activity. The
transcripts were generated according to the protocol for MeV
RNA sequences. We again observed a correlation (cor = 0.583) of
the AU content of the tested sequences and their immunostimu-
latory potential (Figure S 7a and b). These data are consistent
with the in vitro analysis of MeV RNA sequences indicating that the
AU composition of RNA might play a general role in activating
RLR signaling.
In vitro transcripts with a low proportion of AU strongly
stimulate ATP hydrolysis by MDA5
Finally, we asked whether the ATP hydrolysis activity of MDA5
correlates with the immunostimulatory potential of the tested
IVTs. We measured the ATP hydrolysis rate of recombinant
mouse MDA5 in the presence of RNA transcripts (Figure 7 and
Figure S8) and observed a negative correlation between the
maximum number of sequencing reads in the MDA5 library and
the ATP hydrolysis rate (cor = 20.414, Figure 7c). Analysis of the
in vitro data revealed that AU-rich sequences lead to a decrease in
ATP hydrolysis activity of MDA5 (cor = 20.445). Furthermore,
the ATP hydrolysis rate negatively correlates with the immu-
nostimulatory potential of RNA transcripts (cor = 20.426)
(Figure 7d). This result suggests that the ATPase hydrolysis
activity of MDA5 is not correlated to the binding and the
immunostimulatory potential of the RNA transcripts and could
therefore provide a model of RNA recognition by the protein.
The data are consistent with previous work on MDA5 filament
formation upon dsRNA binding [26,27]. In structural and
biophysical studies, Berke et al showed that ATP hydrolysis by
MDA5 causes filaments to disassemble, perhaps by inducing
translocation along the RNA or triggering a conformational
change in the protein. According to our data, this may explain
the observed inverse correlation between the immunostimulatory
activity of IVTs and their potential to induce the ATPase activity
of MDA5.
Discussion
Until now, in vivo RLR ligands were poorly understood and
a naturally occurring MDA5 ligand could only be purified
indirectly by immunoprecipitation of LGP2:RNA complexes from
virus-infected cells overexpressing LGP2 [54]. By applying a
combination of RNA-protein crosslinking, immunoprecipitation of
endogenous proteins and RNA deep sequencing analysis, we were
able to investigate RLR-associated RNA from MeV infected cells.
We compared our results to the empty GFP antibody control
resembling a previously published immunoprecipitation strategy
[20].
Our approach reveals that MDA5 preferentially binds measles
virus RNA of positive polarity, whereas RIG-I additionally binds to
(2) sense RNA within the trailer region as well as in the adjacent L
gene. We propose that enriched RNA of positive polarity most
likely represents mRNA species, since antigenomic RNA is only
generated during replication and is immediately packed into
nucleocapsids [55–57]. For Mononegavirales, these RNA-protein
complexes are considered inaccessible for cytoplasmic proteins
[55,58] and might not be ligands for RLR proteins unless they
become released. We show that, unlike MDA5, RIG-I binds (+)
sense RNA originating from not only the L genomic segment,
but also from the 39 end of the MeV genome, which could be
either le-N read-through transcripts or abortive replication
products comprising 59-triphosphate ends [45,46]. Furthermore,
we hypothesize that RIG-I specific enriched RNA of negative
polarity represents abortive replication products also having
59-triphosphate ends [20–23]. Additionally, 59-copyback DI
sequences combining vRNA of positive and negative polarity
were found both in RIG-I and MDA5 immunoprecipitates and
may contribute to recognition [49].
Bioinformatics analysis and in vitro transcription experiments
revealed a correlation between AU content and read coverage of
the obtained sequences or IVTs, respectively. As shown before
[59], this indicates that RNA rich in AU could serve as a putative
ligand for RIG-I and MDA5, or in a secondary manner lead to a
specific structure that is recognized by both proteins. The slightly
weaker correlation of RIG-I associated sequences with their AU
content compared to MDA5 bound RNAs could be explained by
additional sequences or triphosphate RNAs recognized by RIG-I
that originate from regions less rich in AU.
Interestingly, ATP hydrolysis assays performed with recombi-
nant MDA5 and RNA transcripts indicate that the AU content of
RNA negatively correlates with the ATP hydrolysis rate of the
protein. This inverse correlation between the immunostimulatory
potential of RNAs and their capability to stimulate ATP hydrolysis
by MDA5 lets us speculate that the ATPase activity might not be
necessary for, or even interfere with, the immunoactivity of RNA
ligands. Although this observation disagrees with recent findings
about the role of ATP hydrolysis in RIG-I oligomerization on
59-triphosphate dsRNA [60], we assume that MDA5 and RIG-I
differ markedly in their mechanical activation and the role of ATP
hydrolysis. Our data is supported by results suggesting that MDA5
filament formation is abrogated in an ATP-sensitive manner. By
electron microscopy (EM) analysis it was shown that MDA5
filaments disassemble in the presence of ATP, indicating that
ATP hydrolysis triggers the translocation of the protein along
the dsRNA molecule or reduces the binding affinity, thereby
interfering with downstream signaling [26,27]. In light of the
available data in the literature we therefore hypothesize that the
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Figure 7. Analysis of in vitro transcribed RNA of the measles virus genome. Sequences were generated according to deep sequencing data.
The transcripts were either transfected into 293T ISRE-FF reporter cells in order to validate the immunostimulatory potential or ATPase hydrolysis
experiments were performed in presence of recombinant mMDA5. A: Comparison of relative luciferase activities (black) and relative ATPase activities
(grey) of in vitro transcribed RNAs (n = 3 and n = 2 respectively, values were normalized to the highest mean value of each replicate). B: Pearson
correlation between (+) RNA maximal coverage and relative luciferase activity. C: Pearson correlation between (+) RNA maximal coverage and relative
ATPase activity. D: Correlation analysis between AU content and luciferase or ATPase activity, and between ATPase and luciferase activity.
doi:10.1371/journal.ppat.1004081.g007
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ATPase activity of the MDA5 helicase domain contributes to
substrate specificity by detaching the protein from low affinity
substrates. To further test this hypothesis we generated RIG-
IE373Q and MDA5E444Q, which are mutated in the ‘‘Walker B’’
ATP hydrolysis motif [61], slowing down or abrogating the ATP
hydrolysis activity of the proteins, while preserving formation
of ATP complexes. Overexpression of these mutant proteins
from transfected plasmids showed a dramatic increase in their
immunostimulatory potential in the absence of any viral ligands
in comparison to expressed wild-type MDA5 (Figure S9).
Furthermore, pull-down studies with the RIG-I Walker B mutant
revealed an increase in the amount of recovered RNA while
their immunostimulatory potential decreased (data not shown).
The increased immunostimulation of ATPase deficient RLRs is
consistent with the model that RNAs that lead to a reduced ATP-
hydrolysis rate are more proficient in immunostimulation, possibly
by stabilizing RLR:RNA complexes. The negative correlation
between AU-rich sequences and the ATP hydrolysis rate suggests
that MDA5 binds AU-rich RNA in preference to GC-rich RNA.
This would lead to a stronger interaction between RNA and
MDA5 and result in a higher immunostimulatory signal. In order
to test this hypothesis, we performed binding assays with MDA5
and IVTs but we were not able to demonstrate differences in
the binding affinities between the different transcripts that might
support this theory (data not shown). Finally, we speculate that
RNA ligands for RLR proteins could be divided into two classes.
The first class would comprise RNA molecules originating from
the 59-triphosphate ends of the genome or antigenome. These
molecules could be generated in the course of read-through
transcription and abortive replication [45,46] and could therefore
represent preferred ligands of RIG-I, as shown previously [20].
The second class of RNA molecules could be recognized by both
receptor proteins. Our data suggest that recognition of these RNAs
might occur through the AU composition of sequences [34]. This
second class might also prominently include defective interfering (DI)
particles generated during MeV replication. For MDA5, however,
our deep sequencing data show that the (2) strand portion of the DIs
is either relatively short or the fraction of DIs binding to MDA5 is
magnitudes lower than the binding to L derived (+) sense RNAs and
therefore not easily detectable during sequencing. A more detailed
analysis of the deep sequencing data is currently ongoing in order to
shed more light on the complex nature of the DIs involved.
It will be interesting to see what types of RNA associate with
RIG-I and MDA5 during infections with different viruses and to
what extent the AU composition and DI generation contributes
to RNA recognition in these types of viruses. In particular, the
finding that both RIG-I and MDA5 localize to AU rich regions
suggests partially overlapping roles in detection of different viruses.
The specificity of RIG-I and MDA5 for certain viruses may lie not
only in the detection of 59-triphosphate by RIG-I, but also in the
heterogeneity of viral evasion strategies [62]. Our findings support
a model for the recognition of AU-rich sequences by RIG-I and
MDA5 from MeV-infected cells. Consistently, we find a similar
correlation for in vitro transcribed RNA from the Mengo virus
genome.
In general, the data support previous experiments indicating
that MeV is mainly recognized by RIG-I, while MDA5 seems to
play a minor role [4,5,13,63]. It could be possible that RIG-I
initially recognizes le-N read-through transcripts or abortive
replication products containing 59-triphosphate ends, leading to
the activation of the signaling cascade. In a second round of
recognition, RIG-I and MDA5 then recognize viral transcripts
that are rich in AU. To further test this hypothesis, time dependent
experiments need to be carried out.
One feature of the applied crosslinking technique is the
introduction of specific T to C transitions at the interaction sites
of 4SU-labeled RNA and the protein upon UV light exposure
[37]. By identifying these point mutations in the deep sequencing
data, one can exactly pinpoint the RNA sequences that interact
with the protein of interest. However, our bioinformatics analysis
did not reveal significant enrichment of T to C mutations, which
could be explained by the rather low incorporation efficiency of
the photoreactive nucleoside into viral RNA, consistent with the
low incorporation level of 4SU into host RNA. Nevertheless, by
increasing the incorporation efficiency in future studies, the
identification of point mutants could further narrow down the
precise binding sites of RLRs.
In summary, our approach provides a first insight into the
molecular basis of vRNA derived from MeV interaction with
MDA5 in living cells and reveals a preference for binding of AU-
rich regions originated from (+)-sense RNA of the L gene. In vitro,
these RNA molecules appear to be a poorer stimulator of the
ATPase activity of MDA5, and result in more stable MDA5
filaments and support better downstream signaling.
Materials and Methods
Cell lines, viruses and antibodies
Infection experiments were carried out in A459 human lung
carcinoma cells. HEK 293T ISRE-FF reporter cells (stable
expression of firefly luciferase under the control of an interferon
stimulated response element) were used for interferon stimulation
luciferase reporter gene assays. All cells were maintained in
Dulbecco’s Modified Eagle Medium supplemented with 2 mM L-
glutamine, 1% Penicillin-Streptomycin and 10% FBS (all purchased
from Invitrogen). Viruses used for infections were recombinant
measles virus with a sequence identical to the vaccine strain Schwarz
(AF266291.1.), Sendai virus, Sendai virus defective interfering
particles H4 (kindly provided by Dominique Garcin, Geneva,
Switzerland), Mengo virus strain pMC0 (kindly provided by Anne
Krug, TU Munich, Germany) and EMCV. Primary antibodies to
human MDA5 (AT113) and RIG-I (Alme-1) were purchased from
Enzo Life Science (Loerrach, Germany). Antibody to GFP (ab1218)
was obtained from Abcam (Cambridge, UK). Secondary antibodies
were supplied by GE Healthcare (Buckinghamshire, UK).
Crosslinking and immunoprecipitation of RLR-associated
RNA from virus-infected cells
A549 cells were infected with virus with an MOI of 1.0 in the
presence of 400 mM 4SU. Infection was allowed to proceed for
24 h and living cells were washed with PBS (10 mM phosphate,
137 mM NaCl, 2.7 mM KCl, pH 7.5) and exposed to 1 J/cm2
365 nm UV light using a photocrosslinker (Vilbert Lourmat). Cells
were harvested and incubated in Nonidet P-40 lysis buffer (50 mM
HEPES, 150 mM KCl, 1 mM NaF, 10 mM ZnCl2, 0.5% NP-40,
0.5 mM DTT, protease inhibitor, pH 7.5) for 10 min on ice. The
lysate was cleared by centrifugation and endogenous proteins were
immunoprecipitated for 4 h with the respective antibodies (1 mg/
mL) bound to protein G Dynabeads (Life Technologies). The beads
were washed five times with high-salt wash buffer (50 mM HEPES,
500 mM KCl, 0.05% NP-40, 0.5 mM DTT, protease inhibitor,
pH 7.5) and incubated with proteinase K (Thermo Scientific) for
30 min at 55uC. The RNA was isolated by phenol/chloroform/
isoamylalcohol extraction and subjected to further analysis.
Total RNA isolation from virus infected cells
A549 cells were infected with MeV with an MOI of 1. Cells
were harvested 24 hpi. Total RNA was isolated according to
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manufacturer’s protocol of the RNeasy Protect Mini Kit (Qiagen)
and subjected to Illumina deep sequencing.
Luciferase transfection assay
Immunoactivity experiments were carried out in 24-well plates.
2.56105 HEK 293T ISRE-FF reporter cells were transfected with
250 ng of recovered RNA, 500 ng in vitro transcripts or 500 ng
plasmid DNA using Lipofectamine 2000 (Invitrogen) according
to manufacturer’s protocol. After 24 h incubation, cells were
subjected to immunoactivity experiments using the Dual-Glo
luciferase assay system (Promega) according to manufacturer’s
instructions. The luciferase activity was determined in a 96-well
plate reader. Significance of differences in luciferase activity
between samples were determined via an unpaired t-test.
cDNA library preparation and deep sequencing analysis
Isolated RNA was prepared for Illumina sequencing using
the mRNA-Seq library preparation kit (Epicentre) according to
manufacturer’s protocol. To remove ribosomal RNA species from
the sequencing libraries a Ribo-Zero rRNA removal kit (Epicen-
tre) was used. Quality of RNA-Seq libraries was validated on a
DNA1500 chip for the Bioanalyzer 2100 (Agilent). Sequencing
was performed on the Illumina Genome Analyzer in the Gene
Center sequencing facility (LAFUGA). Obtained sequences were
processed with the FASTX toolkit (http://hannonlab.cshl.edu/
fastx_toolkit/) in order to remove adapter sequences and reads
with PHRED scores below 30. Remaining sequences were
mapped to human and viral genomes by utilization of the Bowtie
algorithm [64], allowing maximal one mismatch per unique read.
The Bowtie sequence alignments were converted with SAMtools
[65] to pileup format, which was subsequently used for further data
analysis. Relative sequence abundances were analyzed between
RLR pull-down samples and the GFP control. Specific read
enrichments were calculated by determining the relative sequence
abundance at each position on the genomic segment and calculating
the average of the RLR/GFP ratios over a dynamic window of 200
reads. Relative sequence abundances with log2 ratios above +1 were
defined as significantly enriched in the RLR library.
Analysis of RNA sequences
RNA secondary structure prediction from measles virus genome
or in vitro transcripts was performed by utilization of RNAfold from
the ViennaRNA package [53] using standard parameter settings.
For this purpose, the genome was divided into 201 nt fragments
with a shifting window size of 5 nt. The sequences were folded in
silico and the linear relationship between different data sets was
quantified with the Pearson correlation coefficient.
SYBR green quantitative PCR analysis
DNase treatment of the immunoprecipitated RNAs and qPCR
was performed as previously described [66]. The primer pairs
used for quantification were identical to those published [67]. For
cDNA synthesis a random hexanucleotide mix was used (Roche).
Full length MeV vac2 cDNA with a known concentration was
used for standard generation. Copy number values obtained for
MDA5 and RIG-I were normalized to the control GFP.
PCR for 59-copyback defective interfering genome
detection
Specific primers for reverse transcription (Roche transcriptor
transcriptase) and the subsequent PCR (Biozym Phusion Poly-
merase) were adapted from Calain et al [47]. PCR products were
analyzed on agarose gels and stained with ethidium bromide.
T7 RNA transcription
Templates were generated for in vitro transcription in a PCR
adding the T7 promoter sequence (TAATACGACTCACTATA
GGG) to the 59 end of the desired MeV or Mengo virus genomic
fragment, respectively (for oligonucleotides see Tables S2 und
S4 respectively). PCR products were subsequently purified on
agarose gels. RNA was transcribed using the Ambion Megashort-
script T7 Kit according to the manufacturer’s protocols. The
reaction was incubated overnight at 37uC and RNA was precipitated
using LiCl at 220uC for 30 minutes. Afterwards, RNA was
subjected to triphosphate digestion using FastAP (Fermentas)
according to the manufacturer’s instructions and purified on
denaturing 8 M urea/10% polyacrylamide gels at 25 mA constant
current. Gel slices containing RNA were incubated overnight with
450 mL probe elution buffer (0.5 M ammonium acetate, 1 mM
EDTA, 0.2% SDS). Eluted RNA was isolated by phenol/
chloroform/isoamylalcohol extraction and precipitated with ethanol.
ATPase hydrolysis assays
ATPase hydrolysis activity was determined using [c-P32] ATP.
Mouse MDA5 was purified as described previously [32] and
1.6 mM of protein was preincubated with 80 nM in vitro
transcribed RNA for 10 min at room temperature. The reaction
was initiated by addition of ATPase hydrolysis buffer (20 mM
HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, and 2 mM
DTT) containing 2 mM ATP and 0.2 mCi [c-P32] ATP. The
hydrolysis rate was monitored over 1 h and analyzed by thin layer
chromatography (TLC).
Generation of RLR mutants
Sequences encoding full-length human RIG-I with N-terminal
FLAG-tag and full-length human MDA5 with N-terminal FLAG-
tag were cloned into pcDNA5 FRT/TO (Invitrogen). Mutants
(FLAG-RIG-I E373Q and FLAG-MDA5 E444Q) were generated
by site directed mutagenesis with PfuUltra (Agilent).
Supporting Information
Figure S1 Validation of immunostimulatory activity of
RNA from RIG-I, MDA5, and GFP immunoprecipitates
upon transfection into 293T ISRE-FF reporter cells (n = 3,
** P,0.01).
(TIF)
Figure S2 Deep sequencing analysis of total RNA from
MeV-infected cells 24 hpi. RNA was isolated according to
manufacturer’s protocol of the RNeasy Protect Mini Kit (Qiagen)
and total RNA was subjected to Illumina deep sequencing. The
data show an mRNA gradient declining in the 59 to 39 direction,
while RNA of negative polarity has no relevant copy numbers.
(TIF)
Figure S3 Qualitative PCR analysis of MeV copyback DI
RNA. Following a specific reverse transcription of RNA with a
primer binding at the 39-terminus of the antigenome, 59-copyback
DI genomes were specifically amplified using another primer in
the same direction 600 nt downstream. The PCR was afterwards
analyzed on agarose gels to separate the amplicons of specific
copyback DIs with different length and branching points. The
RNA used for these experiments is indicated on the lanes (RIG-I,
MDA5 and GFP immunoprecipitates).
(TIF)
Figure S4 Enrichments in RLR sequencing libraries.
Binary logarithms of RLR to GFP ratios of sequence reads
(log2([read number RLR/read number GFP] * [total read number
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GFP/total read number RLR])) were calculated in order to
determine specific accumulations within the RLR libraries. Data
points with log2 ratios above 1 represent sequencing reads that were
enriched in comparison to the control (GFP) library. A: Enrich-
ments within the whole RIG-I (+) or (2) stranded sequencing
library. B: Enrichments within the whole MDA5 (+) or (2) stranded
sequencing library. C: Similar to A and B, but zoomed in view of
the enrichments for positive polarity (le)N and L segments. Mean
values for RIG-I and MDA5 log2 ratios are shown in red and blue,
respectively. Standard deviations are represented in grey. The mean
coverage of (+) RNA sequences is shown for the RIG-I (red), MDA5
(blue), and GFP (black) libraries below each graph.
(TIF)
Figure S5 Secondary structure analysis of several
features from in silico folded 201 nucleotide MeV RNA
fragments and correlation to the fragment’s mean
coverage within the RIG-I sequencing library. In silico
folding was done with RNAfold using standard parameters. The
analysis is visualized in heatscatter plots and the linear correlation
is expressed via the Pearson coefficient. Every dot corresponds to
one fragment with its depicted feature and mean coverage. The
more yellow the plot, the more data points overlap. Analyzed
RNA features are: number of paired nucleotides, longest paired
stretch, number of stem-loops, mean size of stem-loops, number of
bulges, mean size of bulges and mean number of paired
nucleotides per branch. A: Correlation analysis of RNA secondary
structure features with the RIG-I associated RNA of positive
polarity. B: Correlation analysis of RNA secondary structure
features with the RIG-I associated RNA of negative polarity.
(TIF)
Figure S6 RNA secondary structure analysis of several
features from in silico folded 201 nucleotide MeV RNA
fragments and correlation to the fragment’s mean
coverage within the RIG-I sequencing library. Foldings
were performed with RNAfold using standard parameters. The
analysis is visualized in heatscatter plots and the linear correlation
is expressed via the Pearson coefficient. Every dot corresponds to
one fragment with its depicted feature and mean coverage. The
more yellow the plot, the more data points overlap. Analyzed
RNA features are: number of paired nucleotides, longest paired
stretch, number of stem-loops, mean size of stem-loops, number of
bulges, mean size of bulges and mean number of paired
nucleotides per branch. A: Correlation analysis of RNA secondary
structure features with the RIG-I associated RNA of positive
polarity. B: Correlation analysis of RNA secondary structure
features with the RIG-I associated RNA of negative polarity.
(TIF)
Figure S7 Analysis of in vitro transcribed RNA of the
Mengo virus genome. Six 201 nt fragments were chosen to
include low and high AU content. Transcripts were transfected
into 293T ISRE-FF reporter cells in order to validate the
immunostimulatory potential. A: Relative luciferase activity of
transfected RNA (n = 3). B: Pearson correlation between (+) RNA
maximal coverage and the relative luciferase activity.
(TIF)
Figure S8 MDA5 ATPase activity assay. Free phosphate
was separated by thin layer chromatography (TLC) and visualized
on a Storm PhosphorImager from Molecular Dynamics. The
ATPase hydrolysis rate was determined by quantifying free
phosphate in comparison to non-hydrolyzed ATP 15 min after
adding [c-P32] ATP to the reaction mixture.
(TIF)
Figure S9 Immunostimulatory activity of overex-
pressed Walker B mutants RIG-IE373Q and MDA5E444Q
compared to wildtype proteins in 293T ISRE-FF reporter
cells (n = 3, ** P,0.01, *** P,0.001).
(TIF)
Table S1 Sequences of in vitro transcribed MeV RNAs.
The gene annotation with the exact nucleotide position on the
MeV genome is shown in brackets.
(DOCX)
Table S2 Oligonucleotides used for generation of in
vitro transcribed MeV sequences.
(DOCX)
Table S3 Sequences of in vitro transcribed Mengo
RNAs. The gene annotation with the exact nucleotide position
on the Mengo virus genome is shown in brackets.
(DOCX)
Table S4 Oligonucleotides used for generation of in
vitro transcribed Mengo sequences.
(DOCX)
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